← Browse by Condition
Medical Condition

schizo affective disorder

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 4, Phase 1, Phase 2, Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for schizo affective disorder sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — schizo affective disorder Clinical Trials

How many clinical trials are currently recruiting for schizo affective disorder?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for schizo affective disorder, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for schizo affective disorder?
schizo affective disorder research spans Phase 1 (1 trial), Phase 2 (2 trials), Phase 3 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a schizo affective disorder clinical trial?
Eligibility criteria for schizo affective disorder trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
1
Top Sponsors
Nathan Kline Institute for Psychiatric Research 1 trial
University of Massachusetts, Worcester 1 trial
Vishwajit Nimgaonkar, MD PhD 1 trial
Michigan State University 1 trial

Recruiting Clinical Trials

NCT07469384
Recruiting
Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways
Enrollment
120 pts
Location
United States
Sponsor
Nathan Kline Institute for Psy...
View Trial →
NCT06174116 Phase 4
Recruiting
Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia
Enrollment
50 pts
Location
United States
Sponsor
University of Massachusetts, W...
View Trial →
NCT03794076 Phase 1, Phase 2
Recruiting
Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia
Enrollment
160 pts
Location
United States
Sponsor
Vishwajit Nimgaonkar, MD PhD
View Trial →
NCT06529029 Phase 2, Phase 3
Recruiting
Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy
Enrollment
30 pts
Location
United States
Sponsor
Michigan State University
View Trial →

Related Conditions

schizophrenia (2) schizophrenia 1 disorder (1) suicidal ideation (1) major depressive disorder (1) bipolar disorder (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology